Moccia, F.; Brunetti, V.; Soda, T.; Faris, P.; Scarpellino, G.; Berra-Romani, R.
Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy. J. Clin. Med. 2023, 12, 5295.
https://doi.org/10.3390/jcm12165295
AMA Style
Moccia F, Brunetti V, Soda T, Faris P, Scarpellino G, Berra-Romani R.
Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy. Journal of Clinical Medicine. 2023; 12(16):5295.
https://doi.org/10.3390/jcm12165295
Chicago/Turabian Style
Moccia, Francesco, Valentina Brunetti, Teresa Soda, Pawan Faris, Giorgia Scarpellino, and Roberto Berra-Romani.
2023. "Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy" Journal of Clinical Medicine 12, no. 16: 5295.
https://doi.org/10.3390/jcm12165295
APA Style
Moccia, F., Brunetti, V., Soda, T., Faris, P., Scarpellino, G., & Berra-Romani, R.
(2023). Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy. Journal of Clinical Medicine, 12(16), 5295.
https://doi.org/10.3390/jcm12165295
